Core Viewpoint - The Perrigo Company plc is facing a class action lawsuit due to alleged violations of the Securities Exchange Act of 1934, with claims that the company and its executives made misleading statements regarding the financial health of its infant formula business acquired from Nestlé [1][3]. Summary by Sections Class Action Lawsuit Details - The class action lawsuit is titled French v. Perrigo Company plc and covers securities purchases made between February 27, 2023, and November 4, 2025 [1]. - Investors have until January 16, 2026, to seek appointment as lead plaintiff in the lawsuit [1]. Allegations Against Perrigo - The lawsuit alleges that Perrigo's acquisition of Nestlé's Gateway infant formula plant was plagued by significant underinvestment and operational deficiencies [3]. - Specific claims include the need for substantial capital expenditures beyond initial estimates to address these issues, leading to overstated financial results [3]. Financial Impact and Stock Performance - On February 27, 2024, Perrigo disclosed acquisition-related charges of $35 million to $45 million for remediation efforts, resulting in a 50% decline in earnings per share compared to the previous year [4]. - Following this announcement, Perrigo's stock price fell over 15% [4]. - On May 7, 2024, Perrigo reported net sales of $91 million, a decrease of 34.5%, and a gross margin decline of 90 basis points, leading to a nearly 10% drop in stock price [5]. - On August 6, 2025, Perrigo's adjusted gross profit decreased by $30 million (6.9%), with a reported gross margin of 34.4%, causing an 11% decline in stock price [6]. - On November 5, 2025, Perrigo announced a strategic review of its infant formula business and slashed its fiscal year 2025 outlook, resulting in a stock price drop of over 25% [7]. Company Background - Perrigo provides over-the-counter health and wellness solutions and has been involved in significant acquisitions to expand its product offerings [2].

San Diego, California--(Newsfile Corp. - December 9, 2025) - Robbins Geller Rudman & Dowd LLP announces that purchasers or acquirers of Perrigo Company plc (NYSE: PRGO) securities between February 27, 2023 and November 4, 2025, inclusive (the "Class Period"), have until Friday, January 16, 2026 to seek appointment as lead plaintiff of the Perrigo class action lawsuit. Captioned French v. Perrigo Company plc, No. 25-cv-09596 (S.D.N.Y.), the Perrigo class action lawsuit charges Perrigo and certain of Perrigo ...

Core Viewpoint - The Perrigo Company plc is facing a class action lawsuit due to alleged violations of the Securities Exchange Act of 1934, with claims that the company and its executives made misleading statements regarding the financial health of its infant formula business acquired from Nestlé [1][3]. Summary by Sections Class Action Details - The class action lawsuit is titled French v. Perrigo Company plc, and it covers securities purchases made between February 27, 2023, and November 4, 2025, with a deadline for lead plaintiff applications set for January 16, 2026 [1][2]. Acquisition and Allegations - Perrigo acquired Nestlé's Gateway infant formula plant for $170 million in November 2022, along with rights to the Good Start® brand [2]. - Allegations include significant underinvestment in the acquired infant formula business, necessitating higher-than-expected capital expenditures for remediation [3]. Financial Disclosures and Stock Impact - On February 27, 2024, Perrigo disclosed acquisition-related charges of $35 million to $45 million for remediation, alongside a 50% decline in earnings per share compared to the previous year, leading to a stock price drop of over 15% [4]. - On May 7, 2024, Perrigo reported net sales of $91 million, a decrease of 34.5%, and a gross margin decline of 90 basis points, resulting in a nearly 10% stock price drop [5]. - On August 6, 2025, adjusted gross profit decreased by $30 million (6.9%), with a reported gross margin of 34.4%, causing a stock price decline of more than 11% [6]. - On November 5, 2025, Perrigo announced a strategic review of its infant formula business, slashing its fiscal year 2025 outlook, which led to a stock price drop of over 25% [7].

Core Viewpoint - The article discusses a class action lawsuit against Perrigo Company plc, alleging violations of the Securities Exchange Act of 1934 due to misleading statements and undisclosed issues related to its acquisition of Nestlé's infant formula business [1][2]. Company Overview - Perrigo Company plc is involved in providing over-the-counter health and wellness solutions [1]. - The company acquired Nestlé's Gateway infant formula plant and the rights to the Good Start® brand for $170 million in November 2022 [1]. Allegations and Financial Impact - The lawsuit claims that Perrigo's executives made false statements regarding the condition of the acquired infant formula business, which suffered from underinvestment and significant operational deficiencies [1]. - On February 27, 2024, Perrigo disclosed additional costs of $35 million to $45 million for remediation, leading to a 50% decline in earnings per share compared to the previous year [1]. - Following further disclosures, Perrigo's stock price fell over 15% on February 27, 2024, nearly 10% on May 7, 2024, and more than 11% on August 6, 2025, due to ongoing issues with the infant formula business [1]. - On November 5, 2025, Perrigo announced a strategic review of its infant formula business and revised its fiscal year 2025 outlook, resulting in a stock price drop of over 25% [1]. Legal Process - Investors who purchased Perrigo securities during the class period (February 27, 2023, to November 4, 2025) can seek appointment as lead plaintiff in the class action lawsuit [1]. - The lead plaintiff will represent the interests of all class members and can select a law firm to litigate the case [1].

Core Viewpoint - The Perrigo Company plc is facing a class action lawsuit due to alleged violations of the Securities Exchange Act of 1934, with claims that the company and its executives made misleading statements regarding the financial health of its infant formula business acquired from Nestlé [1][3]. Group 1: Class Action Details - The class action lawsuit is titled French v. Perrigo Company plc and covers securities purchases made between February 27, 2023, and November 4, 2025, with a deadline for lead plaintiff applications set for January 16, 2026 [1][8]. - The lawsuit alleges that Perrigo's acquisition of Nestlé's Gateway infant formula plant for $170 million was marred by significant underinvestment and operational deficiencies [2][3]. Group 2: Financial Implications - On February 27, 2024, Perrigo disclosed acquisition-related charges of $35 million to $45 million for remediation efforts, alongside a 50% decline in earnings per share compared to the previous year, leading to a stock price drop of over 15% [4]. - On May 7, 2024, Perrigo reported net sales of $91 million, a decrease of 34.5%, and a gross margin decline of 90 basis points, resulting in a nearly 10% drop in stock price [5]. - On August 6, 2025, Perrigo's adjusted gross profit decreased by $30 million (6.9%), with a reported gross margin of 34.4%, causing an over 11% decline in stock price [6]. - On November 5, 2025, Perrigo announced a strategic review of its infant formula business, slashing its fiscal year 2025 outlook, which included a negative sales growth guidance of -2.5% to -3% and a significant cut in expected earnings per share, leading to a stock price drop of over 25% [7].

Core Viewpoint - The Perrigo Company plc is facing a class action lawsuit due to alleged violations of the Securities Exchange Act of 1934, with claims that the company and its executives made misleading statements regarding the financial health of its acquired infant formula business [1][3]. Group 1: Class Action Details - The class action lawsuit is titled French v. Perrigo Company plc and covers securities purchases from February 27, 2023, to November 4, 2025, with a deadline for lead plaintiff applications set for January 16, 2026 [1][2]. - The lawsuit alleges that Perrigo's acquisition of Nestlé's Gateway infant formula plant for $170 million was marred by significant underinvestment and operational deficiencies [2][3]. Group 2: Financial Implications - On February 27, 2024, Perrigo disclosed acquisition-related charges of $35 million to $45 million for remediation efforts, alongside a 50% decline in earnings per share compared to the previous year [4]. - The company reported net sales of $91 million on May 7, 2024, a decrease of 34.5%, attributed to lower shipments during remediation efforts, leading to a nearly 10% drop in stock price [5]. - On August 6, 2025, Perrigo's adjusted gross profit decreased by $30 million, or 6.9%, with a reported gross margin of 34.4%, resulting in an 11% decline in stock price [6]. - On November 5, 2025, Perrigo announced a strategic review of its infant formula business, slashing its fiscal year 2025 outlook, including a net sales growth guidance adjustment from 0%-3% to -2.5% to -3% and adjusted diluted earnings per share from $2.90-$3.10 to $2.70-$2.80, causing a 25% drop in stock price [7].

Core Viewpoint - The Perrigo Company plc is facing a class action lawsuit due to alleged violations of the Securities Exchange Act of 1934, with claims that the company misled investors regarding its infant formula business and financial performance during the specified class period [1][4]. Company Overview - Perrigo provides over-the-counter health and wellness solutions and acquired Nestlé's Gateway infant formula plant and the rights to Nestlé's Good Start® infant formula brand for $170 million in November 2022 [3]. Allegations of the Lawsuit - The lawsuit alleges that Perrigo made false or misleading statements and failed to disclose significant issues, including: - Underinvestment in the acquired infant formula business [4]. - The need for substantial capital and operational expenditures beyond stated estimates for remediation [4]. - Significant manufacturing deficiencies in the infant formula facility [4]. - Overstated financial results, including earnings and cash flow [4]. Financial Disclosures and Impact - On February 27, 2024, Perrigo disclosed acquisition-related charges of $35 million to $45 million for remediation, along with a 50% decline in earnings per share compared to the previous year, leading to a stock price drop of over 15% [5]. - On May 7, 2024, Perrigo reported net sales of $91 million, a decrease of 34.5%, and a gross margin decline of 90 basis points, resulting in a nearly 10% drop in stock price [6]. - On August 6, 2025, Perrigo's adjusted gross profit decreased by $30 million (6.9%), with a reported gross margin of 34.4%, causing a stock price decline of more than 11% [7]. - On November 5, 2025, Perrigo announced a strategic review of its infant formula business, slashing its fiscal year 2025 outlook, which included a negative sales growth guidance of -2.5% to -3% and a significant cut in expected earnings per share, leading to a stock price drop of over 25% [8].

Core Viewpoint - The Perrigo Company plc is facing a class action lawsuit due to alleged violations of the Securities Exchange Act of 1934, with claims that the company and its executives made misleading statements regarding the financial health of its infant formula business acquired from Nestlé [1][3]. Company Overview - Perrigo provides over-the-counter health and wellness solutions and acquired Nestlé's Gateway infant formula plant and the rights to the Good Start® brand for $170 million in November 2022 [2]. Allegations of Misleading Statements - The lawsuit alleges that Perrigo failed to disclose significant underinvestment in the acquired infant formula business, which required substantial capital expenditures beyond initial estimates to address operational deficiencies [3]. - Specific allegations include manufacturing deficiencies and overstated financial results, including earnings and cash flow [3]. Financial Impact and Stock Performance - On February 27, 2024, Perrigo disclosed acquisition-related charges of $35 million to $45 million for remediation efforts, leading to a 50% decline in earnings per share compared to the previous year [4]. - Following this announcement, Perrigo's stock price fell over 15% [4]. - On May 7, 2024, Perrigo reported net sales of $91 million, a decrease of 34.5%, and a gross margin decline of 90 basis points, resulting in a nearly 10% drop in stock price [5]. - On August 6, 2025, adjusted gross profit decreased by $30 million (6.9%), with a reported gross margin of 34.4%, causing an over 11% decline in stock price [6]. - On November 5, 2025, Perrigo announced a strategic review of its infant formula business and slashed its fiscal year 2025 outlook, leading to a more than 25% drop in stock price [7]. Legal Process - Investors who purchased Perrigo securities during the class period can seek appointment as lead plaintiff in the lawsuit, which allows them to act on behalf of other class members [8][9].

Core Viewpoint - The Perrigo Company plc is facing a class action lawsuit due to alleged violations of the Securities Exchange Act of 1934, with claims that the company and its executives made misleading statements regarding the acquisition and performance of its infant formula business [1][4]. Group 1: Class Action Lawsuit Details - The class action lawsuit is titled French v. Perrigo Company plc and covers securities purchased between February 27, 2023, and November 4, 2025, with a deadline of January 16, 2026, for potential lead plaintiffs to come forward [1]. - The lawsuit alleges that Perrigo's acquisition of Nestlé's Gateway infant formula plant for $170 million was plagued by significant underinvestment and operational deficiencies [3][4]. - Specific allegations include the need for substantial capital expenditures beyond initial estimates, significant manufacturing deficiencies, and overstated financial results [4]. Group 2: Financial Impact and Stock Performance - On February 27, 2024, Perrigo disclosed acquisition-related charges of $35 million to $45 million for remediation efforts, leading to a 50% decline in earnings per share compared to the previous year [5]. - Following a report on May 7, 2024, net sales dropped to $91 million, a decrease of 34.5%, attributed to lower shipments during remediation efforts, causing a nearly 10% drop in stock price [6]. - On August 6, 2025, Perrigo reported a $30 million decrease in adjusted gross profit, a 6.9% decline, and a gross margin drop to 34.4%, resulting in an over 11% decline in stock price [7]. - On November 5, 2025, Perrigo announced a strategic review of its infant formula business, slashing its fiscal year 2025 outlook, which led to a more than 25% drop in stock price [8].